article thumbnail

Cybersecurity dominates pharma industry discussions during Q2 2023: GlobalData

Express Pharma

To manage these data and avoid breaches, consequent damages, and negative impacts on stakeholders, companies are taking help from third-party cybersecurity experts to implement IT security measures to lower the risk of a cybersecurity or data security incident. Some are also maintaining insurance with respect to cybersecurity.”

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

In constructing an ECA, there are additional processes involved, such as planning the best study design, selecting the highest-quality clinical RWD source, defining the most appropriate inclusion/exclusion criteria, and conducting all necessary analyses to ensure the synthetic cohort is well matched to the experimental cohort. .

article thumbnail

Pharmaceutical Market Access: Strategies, Challenges, and Key Trends for Success

Pharma Marketing Network

This is where pharmaceutical market access comes into play. Pharmaceutical market access refers to the process of ensuring a drug is not only approved but also commercially viable, reimbursed, and accessible to patients. Payers demand real-world evidence (RWE) and cost-effectiveness data before granting coverage.

article thumbnail

Budget expectation: Bring GST rate on APIs at par with the formulations

Express Pharma

There has been an amendment under income tax provisions to disallow such expenses incurred by pharmaceutical companies in violation of MCI regulations. – For pharma and medical devices policies, the Department of Pharmaceutical is the nodal agency. –

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone. Fortunately, those steps tend to be the least burdensome in the process.